Bolt Biotherapeutics (BOLT) Operating Leases (2019 - 2025)
Historic Operating Leases for Bolt Biotherapeutics (BOLT) over the last 7 years, with Q3 2025 value amounting to $20.9 million.
- Bolt Biotherapeutics' Operating Leases rose 3605.81% to $20.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.9 million, marking a year-over-year increase of 3605.81%. This contributed to the annual value of $23.0 million for FY2024, which is 3166.26% up from last year.
- Per Bolt Biotherapeutics' latest filing, its Operating Leases stood at $20.9 million for Q3 2025, which was up 3605.81% from $21.6 million recorded in Q2 2025.
- Bolt Biotherapeutics' Operating Leases' 5-year high stood at $23.2 million during Q2 2021, with a 5-year trough of $9.1 million in Q1 2021.
- In the last 5 years, Bolt Biotherapeutics' Operating Leases had a median value of $20.7 million in 2022 and averaged $19.4 million.
- Per our database at Business Quant, Bolt Biotherapeutics' Operating Leases soared by 13533.57% in 2022 and then tumbled by 1585.41% in 2024.
- Over the past 5 years, Bolt Biotherapeutics' Operating Leases (Quarter) stood at $21.9 million in 2021, then decreased by 7.48% to $20.2 million in 2022, then decreased by 13.76% to $17.4 million in 2023, then soared by 31.66% to $23.0 million in 2024, then dropped by 9.01% to $20.9 million in 2025.
- Its Operating Leases was $20.9 million in Q3 2025, compared to $21.6 million in Q2 2025 and $22.3 million in Q1 2025.